Eli Lilly 2010 Annual Report Download - page 51
Download and view the complete annual report
Please find page 51 of the 2010 Eli Lilly annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.-
1 -
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
-
15
-
16
-
17
-
18
-
19
-
20
-
21
-
22
-
23
-
24
-
25
-
26
-
27
-
28
-
29
-
30
-
31
-
32
-
33
-
34
-
35
-
36
-
37
-
38
-
39
-
40
-
41 -
42 -
43 -
44 -
45 -
46 -
47 -
48 -
49 -
50 -
51 -
52 -
53 -
54 -
55 -
56 -
57 -
58 -
59 -
60 -
61 -
62
-
63
-
64
-
65
-
66
-
67
-
68
-
69
-
70
-
71
-
72
-
73
-
74
-
75
-
76
-
77
-
78
-
79
-
80
-
81
-
82
-
83
-
84
-
85
-
86
-
87
-
88
-
89
-
90
-
91
-
92
-
93
-
94
-
95
-
96
-
97
-
98
-
99
-
100
-
101
-
102
-
103
-
104
-
105
-
106
-
107
-
108
-
109
-
110
-
111
-
112
-
113
-
114
-
115
-
116
-
117
-
118
-
119
-
120
-
121
-
122
-
123
-
124
-
125
-
126
-
127
-
128
-
129
-
130
-
131
-
132
-
133
-
134
-
135
-
136
-
137
-
138
-
139
-
140
-
141
-
142
-
143
-
144
-
145
-
146
-
147
-
148
-
149
-
150
-
151
-
152
-
153
-
154
-
155
-
156
-
157
-
158
-
159
-
160
-
161
-
162
-
163
-
164
 |
 |
FORM 10-K
Selected Quarterly Data (unaudited)
ELI LILLY AND COMPANY AND SUBSIDIARIES
(Dollars in millions, except per-share data) 2010 Fourth Third Second First
Revenue ........................................................ $6,187.0 $5,654.8 $5,748.7 $5,485.5
Cost of sales ..................................................... 1,232.2 987.6 1,023.9 1,122.5
Operating expenses ............................................... 3,426.8 2,914.7 2,942.6 2,653.5
Acquired in-process research and development ....................... —— — 50.0
Asset impairments, restructuring, and other special charges ............ 79.0 59.5 27.3 26.2
Other—net, expense (income) ...................................... 39.4 21.7 18.4 (74.5)
Income before income taxes ....................................... 1,409.6 1,671.3 1,736.5 1,707.8
Net income ...................................................... 1,169.6 1,302.9 1,348.9 1,248.1
Earnings per share—basic and diluted ............................... 1.05 1.18 1.22 1.13
Dividends paid per share .......................................... .49 .49 .49 .49
Common stock closing prices
High .......................................................... 38.06 37.77 36.92 37.41
Low .......................................................... 33.66 33.12 32.25 33.95
2009 Fourth Third Second First
Revenue ........................................................ $5,934.2 $5,562.0 $5,292.8 $5,047.0
Cost of sales ..................................................... 1,431.3 1,051.9 947.4 816.4
Operating expenses ............................................... 3,170.0 2,823.9 2,748.6 2,476.5
Acquired in-process research and development ....................... 90.0 ———
Asset impairments, restructuring, and other special charges ............ 37.9 549.8 105.0 —
Other—net, expense .............................................. 67.8 66.9 24.1 70.7
Income before income taxes ....................................... 1,137.2 1,069.5 1,467.7 1,683.4
Net income ...................................................... 915.4 941.8 1,158.5 1,313.1
Earnings per share—basic and diluted ............................... .83 .86 1.06 1.20
Dividends paid per share .......................................... .49 .49 .49 .49
Common stock closing prices
High .......................................................... 37.51 35.15 35.95 40.57
Low .......................................................... 32.47 32.40 31.88 27.47
Our common stock is listed on the New York, London, and Swiss stock exchanges.
39